Related references
Note: Only part of the references are listed.Pomalidomide in Patients with Interstitial Lung Disease due to Systemic Sclerosis: A Phase II, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study
Vivien M. Hsu et al.
JOURNAL OF RHEUMATOLOGY (2018)
Determinants of mortality in systemic sclerosis: a focused review
Dilli Ram Poudel et al.
RHEUMATOLOGY INTERNATIONAL (2018)
Sirtuin1 Protects against Systemic Sclerosis-related Pulmonary Fibrosis by Decreasing Proinflammatory and Profibrotic Processes
Haiyan Chu et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2018)
Therapeutic interleukin-6 blockade reverses transforming growth factor-beta pathway activation in dermal fibroblasts: insights from the faSScinate clinical trial in systemic sclerosis
Christopher P. Denton et al.
ANNALS OF THE RHEUMATIC DISEASES (2018)
Prediction of progression of interstitial lung disease in patients with systemic sclerosis: the SPAR model
Wanlong Wu et al.
ANNALS OF THE RHEUMATIC DISEASES (2018)
Myeloablative Autologous Stem-Cell Transplantation for Severe Scleroderma
K. M. Sullivan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Radiological pleuroparenchymal fibroelastosis associated to limited cutaneous systemic sclerosis: a case report
D. Hassoun et al.
BMC PULMONARY MEDICINE (2018)
Association of Defective Regulation of Autoreactive Interleukin-6-Producing Transitional B Lymphocytes WithDisease in Patients With Systemic Sclerosis
Taher E. Taher et al.
ARTHRITIS & RHEUMATOLOGY (2018)
Factors associated with disease progression in early-diagnosed pulmonary arterial hypertension associated with systemic sclerosis: longitudinal data from the DETECT cohort
Carina Mihai et al.
ANNALS OF THE RHEUMATIC DISEASES (2018)
Riociguat for the treatment of pulmonary arterial hypertension associated with connective tissue disease: results from PATENT-1 and PATENT-2
Marc Humbert et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
Initial combination therapy with ambrisentan and tadalafil in connective tissue disease-associated pulmonary arterial hypertension (CTD-PAH): subgroup analysis from the AMBITION trial
John Gerry Coghlan et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
Update of EULAR recommendations for the treatment of systemic sclerosis
Otylia Kowal-Bielecka et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
Interstitial lung disease increases mortality in systemic sclerosis patients with pulmonary arterial hypertension without affecting hemodynamics and exercise capacity
M. Michelfelder et al.
CLINICAL RHEUMATOLOGY (2017)
Selexipag for the treatment of connective tissue disease-associated pulmonary arterial hypertension
Sean Gaine et al.
EUROPEAN RESPIRATORY JOURNAL (2017)
Monocyte-derived alveolar macrophages drive lung fibrosis and persist in the lung over the life span
Alexander V. Misharin et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2017)
Pulmonary arterial hypertension - progress in understanding the disease and prioritizing strategies for drug development
P. Ghataorhe et al.
JOURNAL OF INTERNAL MEDICINE (2017)
Early-Life Antibiotic Exposure Causes Intestinal Dysbiosis and Exacerbates Skin and Lung Pathology in Experimental Systemic Sclerosis
Heena Mehta et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2017)
Scleroderma Lung Involvement, Autoantibodies, and Outcome Prediction: The Confounding Effect of Time
Svetlana I. Nihtyanova et al.
JOURNAL OF RHEUMATOLOGY (2017)
An MIF Promoter Polymorphism Is Associated with Susceptibility to Pulmonary Arterial Hypertension in Diffuse Cutaneous Systemic Sclerosis
Lara Bossini-Castillo et al.
JOURNAL OF RHEUMATOLOGY (2017)
Severity and features of frailty in systemic sclerosis-associated interstitial lung disease
Sabina A. Guler et al.
RESPIRATORY MEDICINE (2017)
Clinical characteristics and survival of systemic sclerosis patients with pulmonary hypertension and elevated wedge pressure: Observations from the PHAROS cohort
Matthew R. Lammi et al.
RESPIROLOGY (2017)
Prognostic significance of computed tomography criteria for pulmonary veno-occlusive disease in systemic sclerosis-pulmonary arterial hypertension
Michelle J. Connolly et al.
RHEUMATOLOGY (2017)
The status of pulmonary fibrosis in systemic sclerosis is associated with IRF5, STAT4, IRAK1, and CTGF polymorphisms
Wenjie Zhao et al.
RHEUMATOLOGY INTERNATIONAL (2017)
Changes in gene expression profiles in patients with pulmonary arterial hypertension associated with scleroderma treated with tadalafil
Fei-Ying Cheong et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2017)
Rituximab versus cyclophosphamide for the treatment of connective tissue disease-associated interstitial lung disease (RECITAL): study protocol for a randomised controlled trial
Peter Saunders et al.
TRIALS (2017)
A novel multi-network approach reveals tissue-specific cellular modulators of fibrosis in systemic sclerosis
Jaclyn N. Taroni et al.
GENOME MEDICINE (2017)
Mycophenolate Mofetil Versus Placebo for Systemic Sclerosis-Related Interstitial Lung Disease An Analysis of Scleroderma Lung Studies I and II
Elizabeth R. Volkmann et al.
ARTHRITIS & RHEUMATOLOGY (2017)
CCL2 in the Circulation Predicts Long-Term Progression of Interstitial Lung Disease in Patients With Early Systemic Sclerosis Data From Two Independent Cohorts
Minghua Wu et al.
ARTHRITIS & RHEUMATOLOGY (2017)
Short-Term Pulmonary Function Trends Are Predictive of Mortality in Interstitial Lung Disease Associated With Systemic Sclerosis
Nicole S. Goh et al.
ARTHRITIS & RHEUMATOLOGY (2017)
Brief Report: Association of Elevated Adipsin Levels With Pulmonary Arterial Hypertension in Systemic Sclerosis
Benjamin D. Korman et al.
ARTHRITIS & RHEUMATOLOGY (2017)
Role of Stromelysin 2 (Matrix Metalloproteinase 10) as a Novel Mediator of Vascular Remodeling Underlying Pulmonary Hypertension Associated With Systemic Sclerosis
Jerome Avouac et al.
ARTHRITIS & RHEUMATOLOGY (2017)
Early Mortality in a Multinational Systemic Sclerosis Inception Cohort
Yanjie Hao et al.
ARTHRITIS & RHEUMATOLOGY (2017)
Novel lung imaging biomarkers and skin gene expression subsetting in dasatinib treatment of systemic sclerosis-associated interstitial lung disease
Viktor Martyanov et al.
PLOS ONE (2017)
Optical coherence tomography evaluation of pulmonary arterial vasculopathy in Systemic Sclerosis
Johannes P. Schwaiger et al.
SCIENTIFIC REPORTS (2017)
Pathobiology of pulmonary arterial hypertension: understanding the roads less travelled
Anna R. Hemnes et al.
EUROPEAN RESPIRATORY REVIEW (2017)
Mapping and predicting mortality from systemic sclerosis
Muriel Elhai et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
A systematic review of genetic mutations in pulmonary arterial hypertension
Gerardo Garcia-Rivas et al.
BMC MEDICAL GENETICS (2017)
Idiopathic and Systemic Sclerosis-Associated Pulmonary Arterial Hypertension A Comparison of Demographic, Hemodynamic, and SRI Characteristics and Outcomes
Sheila Ramjug et al.
CHEST (2017)
Managing systemic sclerosis-related interstitial lung disease in the modern treatment era
Elizabeth R. Volkmann et al.
JOURNAL OF SCLERODERMA AND RELATED DISORDERS (2017)
Treatment outcome in early diffuse cutaneous systemic sclerosis: the European Scleroderma Observational Study (ESOS)
Ariane L. Herrick et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
Survival and quality of life in incident systemic sclerosis-related pulmonary arterial hypertension
Kathleen Morrisroe et al.
ARTHRITIS RESEARCH & THERAPY (2017)
Improved Cough and Cough-Specific Quality of Life in Patients Treated for Scleroderma-Related Interstitial Lung Disease Results of Scleroderma Lung Study II
Donald P. Tashkin et al.
CHEST (2017)
Endothelial Cells Expressing Endothelial and Mesenchymal Cell Gene Products in Lung Tissue From Patients With Systemic Sclerosis-Associated Interstitial Lung Disease
Fabian A. Mendoza et al.
ARTHRITIS & RHEUMATOLOGY (2016)
An Open-label, Phase II Study of the Safety and Tolerability of Pirfenidone in Patients with Scleroderma-associated Interstitial Lung Disease: the LOTUSS Trial
Dinesh Khanna et al.
JOURNAL OF RHEUMATOLOGY (2016)
Pre-Capillary, Combined, and Post-Capillary Pulmonary Hypertension A Pathophysiological Continuum
Christian F. Opitz et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2016)
Safety and efficacy of subcutaneous tocilizumab in adults with systemic sclerosis (faSScinate): a phase 2, randomised, controlled trial
Dinesh Khanna et al.
LANCET (2016)
Computer-Aided Tomographic Analysis of Interstitial Lung Disease (ILD) in Patients with Systemic Sclerosis (SSc). Correlation with Pulmonary Physiologic Tests and Patient Centred Measures of Perceived Dyspnea and Functional Disability
Fausto Salaffi et al.
PLOS ONE (2016)
Ambrisentan response in connective tissue disease-associated pulmonary arterial hypertension (CTD-PAH) - A subgroup analysis of the ARIES-E clinical trial
Aryeh Fischer et al.
RESPIRATORY MEDICINE (2016)
BSR and BHPR guideline for the treatment of systemic sclerosis
Christopher P. Denton et al.
RHEUMATOLOGY (2016)
Esophageal dilatation and interstitial lung disease in systemic sclerosis: A cross-sectional study
Carrie Richardson et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2016)
Derivation and External Validation of a Prediction Rule for Five-Year Mortality in Patients With Early Diffuse Cutaneous Systemic Sclerosis
Robyn T. Domsic et al.
ARTHRITIS & RHEUMATOLOGY (2016)
Characteristics and Survival of Anti-U1 RNP Antibody-Positive Patients With Connective Tissue Disease-Associated Pulmonary Arterial Hypertension
Vincent Sobanski et al.
ARTHRITIS & RHEUMATOLOGY (2016)
Brief Report: Anti-Eukaryotic Initiation Factor 2B Autoantibodies Are Associated With Interstitial Lung Disease in Patients With Systemic Sclerosis
Zoe E. Betteridge et al.
ARTHRITIS & RHEUMATOLOGY (2016)
Combined Pulmonary Fibrosis and Emphysema in Scleroderma-Related Lung Disease Has a Major Confounding Effect on Lung Physiology and Screening for Pulmonary Hypertension
K. M. Antoniou et al.
ARTHRITIS & RHEUMATOLOGY (2016)
The American College of Rheumatology Provisional Composite Response Index for Clinical Trials in Early Diffuse Cutaneous Systemic Sclerosis
Dinesh Khanna et al.
ARTHRITIS & RHEUMATOLOGY (2016)
Relationship between quantitative radiographic assessments of interstitial lung disease and physiological and clinical features of systemic sclerosis
Donald P. Tashkin et al.
ANNALS OF THE RHEUMATIC DISEASES (2016)
Lung Transplant Outcomes in Systemic Sclerosis with Significant Esophageal Dysfunction A Comprehensive Single-Center Experience
Catherine H. Miele et al.
ANNALS OF THE AMERICAN THORACIC SOCIETY (2016)
Changes in plasma CXCL4 levels are associated with improvements in lung function in patients receiving immunosuppressive therapy for systemic sclerosis-related interstitial lung disease
Elizabeth R. Volkmann et al.
ARTHRITIS RESEARCH & THERAPY (2016)
miR-155 in the progression of lung fibrosis in systemic sclerosis
Romy B. Christmann et al.
ARTHRITIS RESEARCH & THERAPY (2016)
Endothelial to Mesenchymal Transition Contributes to Endothelial Dysfunction in Pulmonary Arterial Hypertension
Robert B. Good et al.
AMERICAN JOURNAL OF PATHOLOGY (2015)
Mechanosignaling through YAP and TAZ drives fibroblast activation and fibrosis
Fei Liu et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2015)
Impaired Bone Morphogenetic Protein Receptor II Signaling in a Transforming Growth Factor-beta-Dependent Mouse Model of Pulmonary Hypertension and in Systemic Sclerosis
Adrian J. Gilbane et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2015)
Ambrisentan and Tadalafil Up-front Combination Therapy in Scleroderma-associated Pulmonary Arterial Hypertension
Paul M. Hassoun et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2015)
2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
Nazzareno Galie et al.
EUROPEAN RESPIRATORY JOURNAL (2015)
Bosentan added to sildenafil therapy in patients with pulmonary arterial hypertension
Vallerie McLaughlin et al.
EUROPEAN RESPIRATORY JOURNAL (2015)
Fresolimumab treatment decreases biomarkers and improves clinical symptoms in systemic sclerosis patients
Lisa M. Rice et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Selexipag for the Treatment of Pulmonary Arterial Hypertension
Olivier Sitbon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Initial Use of Ambrisentan plus Tadalafil in Pulmonary Arterial Hypertension
N. Galie et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Reliability, validity and responsiveness to change of the Saint George's Respiratory Questionnaire in early diffuse cutaneous systemic sclerosis
Beth Wallace et al.
RHEUMATOLOGY (2015)
Survival in systemic sclerosis-pulmonary arterial hypertension by serum autoantibody status in the Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma (PHAROS) Registry
Monique Hinchcliff et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2015)
A comparison of the predictive accuracy of three screening models for pulmonary arterial hypertension in systemic sclerosis
Yanjie Hao et al.
ARTHRITIS RESEARCH & THERAPY (2015)
Predictive Value of Serial High-Resolution Computed Tomography Analyses and Concurrent Lung Function Tests in Systemic Sclerosis
Anna-Maria Hoffmann-Vold et al.
ARTHRITIS & RHEUMATOLOGY (2015)
Pulmonary Function Tests: High Rate of False-Negative Results in the Early Detection and Screening of Scleroderma-Related Interstitial Lung Disease
Yossra A. Suliman et al.
ARTHRITIS & RHEUMATOLOGY (2015)
Survival of Adults With Systemic Sclerosis Following Lung Transplantation A Nationwide Cohort Study
Elana J. Bernstein et al.
ARTHRITIS & RHEUMATOLOGY (2015)
Predictors of lung function decline in scleroderma-related interstitial lung disease based on high-resolution computed tomography: implications for cohort enrichment in systemic sclerosis-associated interstitial lung disease trials
Dinesh Khanna et al.
ARTHRITIS RESEARCH & THERAPY (2015)
Pulmonary veno-occlusive disease: a rare cause of pulmonary hypertension in systemic sclerosis. Case presentation and review of the literature
Ana Maria Daraban et al.
ROMANIAN JOURNAL OF INTERNAL MEDICINE (2015)
Immunochip Analysis Identifies Multiple Susceptibility Loci for Systemic Sclerosis
Maureen D. Mayes et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2014)
Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT study
J. Gerry Coghlan et al.
ANNALS OF THE RHEUMATIC DISEASES (2014)
Unique Predictors of Mortality in Patients With Pulmonary Arterial Hypertension Associated With Systemic Sclerosis in the REVEAL Registry
Lorinda Chung et al.
CHEST (2014)
Anticoagulation and Survival in Pulmonary Arterial Hypertension Results From the Comparative, Prospective Registry of Newly Initiated Therapies for Pulmonary Hypertension (COMPERA)
Karen M. Olsson et al.
CIRCULATION (2014)
Upfront triple combination therapy in pulmonary arterial hypertension: a pilot study
Olivier Sitbon et al.
EUROPEAN RESPIRATORY JOURNAL (2014)
Autologous Hematopoietic Stem Cell Transplantation vs Intravenous Pulse Cyclophosphamide in Diffuse Cutaneous Systemic Sclerosis A Randomized Clinical Trial
Jacob M. van Laar et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
Interstitial lung disease in connective tissue disease-mechanisms and management
Athol U. Wells et al.
NATURE REVIEWS RHEUMATOLOGY (2014)
Proteome-wide Analysis and CXCL4 as a Biomarker in Systemic Sclerosis
L. van Bon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Lung and heart-lung transplantation for systemic sclerosis patients. A monocentric experience of 13 patients, review of the literature and position paper of a multidisciplinary Working Group
David Launay et al.
PRESSE MEDICALE (2014)
Cardiac arrhythmias and conduction defects in systemic sclerosis
Alessandra Vacca et al.
RHEUMATOLOGY (2014)
Development of pulmonary hypertension in a high-risk population with systemic sclerosis in the Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma (PHAROS) cohort study
Vivien M. Hsu et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2014)
Borderline pulmonary arterial pressure in systemic sclerosis patients: a post-hoc analysis of the DETECT study
Scott H. Visovatti et al.
ARTHRITIS RESEARCH & THERAPY (2014)
Derivation and Validation of a Prediction Rule for Two-Year Mortality in Early Diffuse Cutaneous Systemic Sclerosis
Robyn T. Domsic et al.
ARTHRITIS & RHEUMATOLOGY (2014)
Molecular Insights Into Systemic Sclerosis-Associated Interstitial Lung Disease
Richard M. Silver et al.
ARTHRITIS & RHEUMATOLOGY (2014)
Prediction of Pulmonary Complications and Long-Term Survival in Systemic Sclerosis
Svetlana I. Nihtyanova et al.
ARTHRITIS & RHEUMATOLOGY (2014)
Assessment of Brd4 Inhibition in Idiopathic Pulmonary Fibrosis Lung Fibroblasts and in Vivo Models of Lung Fibrosis
Xiaoyan Tang et al.
AMERICAN JOURNAL OF PATHOLOGY (2013)
Borderline Mean Pulmonary Artery Pressure in Patients With Systemic Sclerosis: Transpulmonary Gradient Predicts Risk of Developing Pulmonary Hypertension
Christopher J. Valerio et al.
ARTHRITIS AND RHEUMATISM (2013)
Recommendations for Screening and Detection of Connective Tissue Disease-Associated Pulmonary Arterial Hypertension
Dinesh Khanna et al.
ARTHRITIS AND RHEUMATISM (2013)
Skin Gene Expression Correlates of Severity of Interstitial Lung Disease in Systemic Sclerosis
Shervin Assassi et al.
ARTHRITIS AND RHEUMATISM (2013)
Exercise during cardiac catheterization distinguishes between pulmonary and left ventricular causes of dyspnea in systemic sclerosis patients
W. David Hager et al.
CLINICAL RESPIRATORY JOURNAL (2013)
Serum Interleukin 6 Is Predictive of Early Functional Decline and Mortality in Interstitial Lung Disease Associated with Systemic Sclerosis
Angelo De Lauretis et al.
JOURNAL OF RHEUMATOLOGY (2013)
Targeting of αv integrin identifies a core molecular pathway that regulates fibrosis in several organs
Neil C. Henderson et al.
NATURE MEDICINE (2013)
Macitentan and Morbidity and Mortality in Pulmonary Arterial Hypertension
Tomas Pulido et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Survival after lung transplantation in systemic sclerosis. A systematic review
Irfan Y. Khan et al.
RESPIRATORY MEDICINE (2013)
Microarray profiling reveals suppressed interferon stimulated gene program in fibroblasts from scleroderma-associated interstitial lung disease
Gisela E. Lindahl et al.
RESPIRATORY RESEARCH (2013)
Extent of disease on high-resolution computed tomography lung is a predictor of decline and mortality in systemic sclerosis-related interstitial lung disease
Owen A. Moore et al.
RHEUMATOLOGY (2013)
Mucin 5B promoter polymorphism is associated with idiopathic pulmonary fibrosis but not with development of lung fibrosis in systemic sclerosis or sarcoidosis
Carmel J. Stock et al.
THORAX (2013)
The inclusion of N-terminal pro-brain natriuretic peptide in a sensitive screening strategy for systemic sclerosis-related pulmonary arterial hypertension: a cohort study
Vivek Thakkar et al.
ARTHRITIS RESEARCH & THERAPY (2013)
Scleroderma pathogenesis: a pivotal role for fibroblasts as effector cells
Adrian J. Gilbane et al.
ARTHRITIS RESEARCH & THERAPY (2013)
Screening patients with scleroderma for pulmonary arterial hypertension and implications for other at-risk populations
Johannes P. Schwaiger et al.
EUROPEAN RESPIRATORY REVIEW (2013)
BMP type II receptor deficiency confers resistance to growth inhibition by TGF-β in pulmonary artery smooth muscle cells: role of proinflammatory cytokines
Rachel J. Davies et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2012)
Baseline characteristics and follow-up in patients with normal haemodynamics versus borderline mean pulmonary arterial pressure in systemic sclerosis: results from the PHAROS registry
Sangmee Bae et al.
ANNALS OF THE RHEUMATIC DISEASES (2012)
Severe interstitial lung disease in connective tissue disease: rituximab as rescue therapy
Gregory J. Keir et al.
EUROPEAN RESPIRATORY JOURNAL (2012)
Association between the CTGF-945C/G polymorphism and systemic sclerosis: A meta-analysis
Xiufeng Zhang et al.
GENE (2012)
A multicenter study confirms CD226 gene association with systemic sclerosis-related pulmonary fibrosis
Lara Bossini-Castillo et al.
ARTHRITIS RESEARCH & THERAPY (2012)
An Essential Role for Resident Fibroblasts in Experimental Lung Fibrosis Is Defined by Lineage-Specific Deletion of High-Affinity Type II Transforming Growth Factor β Receptor
Rachel K. Hoyles et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)
Improving the Detection of Pulmonary Hypertension in Systemic Sclerosis Using Pulmonary Function Tests
Benjamin E. Schreiber et al.
ARTHRITIS AND RHEUMATISM (2011)
Lung Tissues in Patients With Systemic Sclerosis Have Gene Expression Patterns Unique to Pulmonary Fibrosis and Pulmonary Hypertension
Eileen Hsu et al.
ARTHRITIS AND RHEUMATISM (2011)
Increased epithelial permeability in pulmonary fibrosis in relation to disease progression
N. S. L. Goh et al.
EUROPEAN RESPIRATORY JOURNAL (2011)
Clinical and Serological Hallmarks of Systemic Sclerosis Overlap Syndromes
Angela Pakozdi et al.
JOURNAL OF RHEUMATOLOGY (2011)
Autologous non-myeloablative haemopoietic stem-cell transplantation compared with pulse cyclophosphamide once per month for systemic sclerosis (ASSIST): an open-label, randomised phase 2 trial
Richard K. Burt et al.
LANCET (2011)
Altered monocyte and fibrocyte phenotype and function in scleroderma interstitial lung disease: reversal by caveolin-1 scaffolding domain peptide
Elena Tourkina et al.
FIBROGENESIS & TISSUE REPAIR (2011)
A higher degree of criticism about the effectiveness of bosentan for digital ulcers in scleroderma patients, as for interstitial disease, is also necessary: comment on the article by Seibold et al Reply
James R. Seibold et al.
ARTHRITIS AND RHEUMATISM (2010)
Systemic sclerosis and bilateral lung transplantation: a single centre experience
R. Saggar et al.
EUROPEAN RESPIRATORY JOURNAL (2010)
Cardiopulmonary Exercise Testing with Right-heart Catheterization in Patients with Systemic Sclerosis
Allan J. Walkey et al.
JOURNAL OF RHEUMATOLOGY (2010)
Improved survival in systemic sclerosis is associated with better ascertainment of internal organ disease: a retrospective cohort study
S. I. Nihtyanova et al.
QJM-AN INTERNATIONAL JOURNAL OF MEDICINE (2010)
Clinical experience with bosentan and sitaxentan in connective tissue disease-associated pulmonary arterial hypertension
Christopher J. Valerio et al.
RHEUMATOLOGY (2010)
Gastroesophageal Reflux Incites Interstitial Lung Disease in Systemic Sclerosis: Clinical, Radiologic, Histopathologic, and Treatment Evidence
Romy B. Christmann et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2010)
A large multicentre analysis of CTGF-945 promoter polymorphism does not confirm association with systemic sclerosis susceptibility or phenotype
B. Rueda et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
Association study of a polymorphism of the CTGF gene and susceptibility to systemic sclerosis in the Japanese population
Y. Kawaguchi et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
The Three-Year Incidence of Pulmonary Arterial Hypertension Associated With Systemic Sclerosis in a Multicenter Nationwide Longitudinal Study in France
Eric Hachulla et al.
ARTHRITIS AND RHEUMATISM (2009)
Longterm Survival Among Patients with Scleroderma-associated Pulmonary Arterial Hypertension Treated with Intravenous Epoprostenol
David B. Badesch et al.
JOURNAL OF RHEUMATOLOGY (2009)
A longitudinal study of anti-RNA polymerase III antibody levels in systemic sclerosis
Svetlana I. Nihtyanova et al.
RHEUMATOLOGY (2009)
Interstitial lung disease in systemic sclerosis - A simple staging system
Nicole S. L. Goh et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2008)
Fibroblast-specific perturbation of transforming growth factor beta signaling provides insight into potential pathogenic mechanisms of scleroderma-associated lung fibrosis - Exaggerated response to alveolar epithelial injury in a novel mouse model
Rachel K. Hoyles et al.
ARTHRITIS AND RHEUMATISM (2008)
Endothelin is a downstream mediator of profibrotic responses to transforming growth factor β in human lung fibroblasts
Xu Shi-wen et al.
ARTHRITIS AND RHEUMATISM (2007)
Effects of 1-year treatment with CycNophosphamilde on outcomes at 2 years in scleroderma lung disease
Donald P. Tashkin et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2007)
Endogenous endothelin-1 signaling contributes to type I collagen and CCN2 overexpression in fibrotic fibroblasts
Shi-Wen Xu et al.
MATRIX BIOLOGY (2007)
A polymorphism in the CTGF promoter region associated with systemic sclerosis
Carmen Fonseca et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Bronchoalveolar lavage cellular profiles in patients with systemic sclerosis-associated interstitial lung disease are not predictive of disease progression
Nicole S. L. Goh et al.
ARTHRITIS AND RHEUMATISM (2007)
Submaximal exercise testing in the assessment of interstitial lung disease secondary to systemic sclerosis: reproducibility and correlations of the 6-min walk test
M. H. Buch et al.
ANNALS OF THE RHEUMATIC DISEASES (2007)
Postnatal induction of transforming growth factor beta signaling in fibroblasts of mice recapitulates clinical, histologic, and biochemical features of scleroderma
Sonali Sonnylal et al.
ARTHRITIS AND RHEUMATISM (2007)
A multicenter, prospective, randomized, double-blind, placebo-controlled trial of corticosteroids and intravenous cyclophosphamide followed by oral azathioprine for the treatment of pulmonary fibrosis in scleroderma
Rachel K. Hoyles et al.
ARTHRITIS AND RHEUMATISM (2006)
Bosentan treatment for pulmonary arterial hypertension related to connective tissue disease: a subgroup analysis of the pivotal clinical trials and their open-label extensions
C. P. Denton et al.
ANNALS OF THE RHEUMATIC DISEASES (2006)
Cyclophosphamide versus placebo in scleroderma lung disease
Donald P. Tashkin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Treatment of pulmonary arterial hypertension with the selective endothelin-A receptor antagonist sitaxsentan
Robyn J. Barst et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)
Single-nucleotide polymorphisms in the SPARC gene are not associated with susceptibility to scleroderma
AL Lagan et al.
RHEUMATOLOGY (2005)
Treprostinil, a prostacyclin analogue, in pulmonary arterial hypertension associated with connective tissue disease
RJ Oudiz et al.
CHEST (2004)
CT features of lung disease in patients with systemic sclerosis: Comparison with idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia
SR Desai et al.
RADIOLOGY (2004)
Fibroblast-specific expression of a kinase-deficient type II transforming growth factor β (TGFβ) receptor leads to paradoxical activation of TGFβ signaling pathways with fibrosis in transgenic mice
CP Denton et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Inhaled iloprost for severe pulmonary hypertension
H Olschewski et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Histopathologic subsets of fibrosing alveolitis in patients with systemic sclerosis and their relationship to outcome
D Bouros et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2002)
Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease -: A randomized, controlled trial
DB Badesch et al.
ANNALS OF INTERNAL MEDICINE (2000)
Share Paper
